Onconetix receives additional notice from Nasdaq

3 hours ago 1

Onconetix (NASDAQ:ONCO) said on Thursday that it has received a delisting letter from Nasdaq, indicating that the company’s failure to file its quarterly report is in violation of its continued listing requirements.
The company has already received a deficiency notice from Nasdaq that the company was not in compliance, given its failure to timely file its annual report.
The company intends to file the Form 10-K and 10-Q as promptly as possible to regain compliance.

Recommended For You